EMEA (Europe, Middle East and Africa) H1N1 Vaccines Market Report 2017

July 2017 | 117 pages | ID: EF739250418EN
QYResearch

Abstracts

In this report, the EMEA H1N1 Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of H1N1 Vaccines for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA H1N1 Vaccines market competition by top manufacturers/players, with H1N1 Vaccines sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Medimmune
• AstraZeneca
• Novartis
• GlaxoSmithKline
• Serum Institute
• Sinovac Biotech
• Zydus Cadila
• BioCSL
• Mitsubishi Tanabe Pharma
• Protein Sciences Corporation
• Baxter International
• Sanofi Pastuer
• Commonwealth Serum Laboratories (CSL)

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• Inactivated vaccines
• Type II

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of H1N1 Vaccines for each application, including

• Swine flu
• Application 2

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) H1N1 Vaccines Market Report 2017

1 H1N1 VACCINES OVERVIEW

1.1 Product Overview and Scope of H1N1 Vaccines
1.2 Classification of H1N1 Vaccines
  1.2.1 EMEA H1N1 Vaccines Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA H1N1 Vaccines Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Inactivated vaccines
  1.2.2 Type II
1.3 EMEA H1N1 Vaccines Market by Application/End Users
  1.3.1 EMEA H1N1 Vaccines Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Swine flu
  1.3.2 Application
1.4 EMEA H1N1 Vaccines Market by Region
  1.4.1 EMEA H1N1 Vaccines Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of H1N1 Vaccines (2012-2022)
  1.5.1 EMEA H1N1 Vaccines Sales and Growth Rate (2012-2022)
  1.5.2 EMEA H1N1 Vaccines Revenue and Growth Rate (2012-2022)

2 EMEA H1N1 VACCINES COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA H1N1 Vaccines Market Competition by Players/Manufacturers
  2.1.1 EMEA H1N1 Vaccines Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA H1N1 Vaccines Revenue and Share by Players (2012-2017)
  2.1.3 EMEA H1N1 Vaccines Sale Price by Players (2012-2017)
2.2 EMEA H1N1 Vaccines (Volume and Value) by Type/Product Category
  2.2.1 EMEA H1N1 Vaccines Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA H1N1 Vaccines Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA H1N1 Vaccines Sale Price by Type (2012-2017)
2.3 EMEA H1N1 Vaccines (Volume) by Application
2.4 EMEA H1N1 Vaccines (Volume and Value) by Region
  2.4.1 EMEA H1N1 Vaccines Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA H1N1 Vaccines Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA H1N1 Vaccines Sales Price by Region (2012-2017)

3 EUROPE H1N1 VACCINES (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe H1N1 Vaccines Sales and Value (2012-2017)
  3.1.1 Europe H1N1 Vaccines Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe H1N1 Vaccines Revenue and Growth Rate (2012-2017)
3.2 Europe H1N1 Vaccines Sales and Market Share by Type
3.3 Europe H1N1 Vaccines Sales and Market Share by Application
3.4 Europe H1N1 Vaccines Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe H1N1 Vaccines Sales Volume by Countries (2012-2017)
  3.4.2 Europe H1N1 Vaccines Revenue by Countries (2012-2017)
  3.4.3 Germany H1N1 Vaccines Sales and Growth Rate (2012-2017)
  3.4.4 France H1N1 Vaccines Sales and Growth Rate (2012-2017)
  3.4.5 UK H1N1 Vaccines Sales and Growth Rate (2012-2017)
  3.4.6 Russia H1N1 Vaccines Sales and Growth Rate (2012-2017)
  3.4.7 Italy H1N1 Vaccines Sales and Growth Rate (2012-2017)
  3.4.8 Benelux H1N1 Vaccines Sales and Growth Rate (2012-2017)

4 MIDDLE EAST H1N1 VACCINES (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East H1N1 Vaccines Sales and Value (2012-2017)
  4.1.1 Middle East H1N1 Vaccines Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East H1N1 Vaccines Revenue and Growth Rate (2012-2017)
4.2 Middle East H1N1 Vaccines Sales and Market Share by Type
4.3 Middle East H1N1 Vaccines Sales and Market Share by Application
4.4 Middle East H1N1 Vaccines Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East H1N1 Vaccines Sales Volume by Countries (2012-2017)
  4.4.2 Middle East H1N1 Vaccines Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia H1N1 Vaccines Sales and Growth Rate (2012-2017)
  4.4.4 Israel H1N1 Vaccines Sales and Growth Rate (2012-2017)
  4.4.5 UAE H1N1 Vaccines Sales and Growth Rate (2012-2017)
  4.4.6 Iran H1N1 Vaccines Sales and Growth Rate (2012-2017)

5 AFRICA H1N1 VACCINES (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa H1N1 Vaccines Sales and Value (2012-2017)
  5.1.1 Africa H1N1 Vaccines Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa H1N1 Vaccines Revenue and Growth Rate (2012-2017)
5.2 Africa H1N1 Vaccines Sales and Market Share by Type
5.3 Africa H1N1 Vaccines Sales and Market Share by Application
5.4 Africa H1N1 Vaccines Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa H1N1 Vaccines Sales Volume by Countries (2012-2017)
  5.4.2 Africa H1N1 Vaccines Revenue by Countries (2012-2017)
  5.4.3 South Africa H1N1 Vaccines Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria H1N1 Vaccines Sales and Growth Rate (2012-2017)
  5.4.5 Egypt H1N1 Vaccines Sales and Growth Rate (2012-2017)
  5.4.6 Algeria H1N1 Vaccines Sales and Growth Rate (2012-2017)

6 EMEA H1N1 VACCINES MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Medimmune
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 H1N1 Vaccines Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Medimmune H1N1 Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 AstraZeneca
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 H1N1 Vaccines Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 AstraZeneca H1N1 Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Novartis
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 H1N1 Vaccines Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Novartis H1N1 Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 GlaxoSmithKline
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 H1N1 Vaccines Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 GlaxoSmithKline H1N1 Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Serum Institute
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 H1N1 Vaccines Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Serum Institute H1N1 Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Sinovac Biotech
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 H1N1 Vaccines Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Sinovac Biotech H1N1 Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Zydus Cadila
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 H1N1 Vaccines Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Zydus Cadila H1N1 Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 BioCSL
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 H1N1 Vaccines Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 BioCSL H1N1 Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Mitsubishi Tanabe Pharma
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 H1N1 Vaccines Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Mitsubishi Tanabe Pharma H1N1 Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Protein Sciences Corporation
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 H1N1 Vaccines Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Protein Sciences Corporation H1N1 Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Baxter International
6.12 Sanofi Pastuer
6.13 Commonwealth Serum Laboratories (CSL)

7 H1N1 VACCINES MANUFACTURING COST ANALYSIS

7.1 H1N1 Vaccines Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of H1N1 Vaccines

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 H1N1 Vaccines Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of H1N1 Vaccines Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA H1N1 VACCINES MARKET FORECAST (2017-2022)

11.1 EMEA H1N1 Vaccines Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA H1N1 Vaccines Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA H1N1 Vaccines Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA H1N1 Vaccines Price and Trend Forecast (2017-2022)
11.2 EMEA H1N1 Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe H1N1 Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt H1N1 Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa H1N1 Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA H1N1 Vaccines Sales Forecast by Type (2017-2022)
11.7 EMEA H1N1 Vaccines Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of H1N1 Vaccines
Figure EMEA H1N1 Vaccines Sales Volume (K Units) by Type (2012-2022)
Figure EMEA H1N1 Vaccines Sales Volume Market Share by Type (Product Category) in 2016
Figure Inactivated vaccines Product Picture
Figure Type II Product Picture
Figure EMEA H1N1 Vaccines Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of H1N1 Vaccines by Application in 2016
Figure Swine flu Examples
Table Key Downstream Customer in Swine flu
Figure Application 2 Examples
Table Key Downstream Customer in Application
Figure EMEA H1N1 Vaccines Market Size (Million USD) by Region (2012-2022)
Figure Europe H1N1 Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe H1N1 Vaccines Revenue (Million USD) Status and Forecast by Countries
Figure Middle East H1N1 Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East H1N1 Vaccines Revenue (Million USD) Status and Forecast by Countries
Figure Africa H1N1 Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa H1N1 Vaccines Revenue (Million USD) Status and Forecast by Countries
Figure EMEA H1N1 Vaccines Sales Volume and Growth Rate (2012-2022)
Figure EMEA H1N1 Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA H1N1 Vaccines Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA H1N1 Vaccines Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA H1N1 Vaccines Sales Share by Players (2012-2017)
Figure 2016 H1N1 Vaccines Sales Share by Players
Figure 2017 H1N1 Vaccines Sales Share by Players
Figure EMEA H1N1 Vaccines Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA H1N1 Vaccines Revenue (Million USD) by Players (2012-2017)
Table EMEA H1N1 Vaccines Revenue Share by Players (2012-2017)
Table 2016 EMEA H1N1 Vaccines Revenue Share by Players
Table 2017 EMEA H1N1 Vaccines Revenue Share by Players
Table EMEA H1N1 Vaccines Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA H1N1 Vaccines Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA H1N1 Vaccines Sales Share by Type (2012-2017)
Figure Sales Market Share of H1N1 Vaccines by Type (2012-2017)
Figure EMEA H1N1 Vaccines Sales Market Share by Type (2012-2017)
Table EMEA H1N1 Vaccines Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA H1N1 Vaccines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of H1N1 Vaccines by Type in 2016
Table EMEA H1N1 Vaccines Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA H1N1 Vaccines Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA H1N1 Vaccines Sales Share by Application (2012-2017)
Figure Sales Market Share of H1N1 Vaccines by Application (2012-2017)
Figure EMEA H1N1 Vaccines Sales Market Share by Application in 2016
Table EMEA H1N1 Vaccines Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA H1N1 Vaccines Sales Share by Region (2012-2017)
Figure Sales Market Share of H1N1 Vaccines by Region (2012-2017)
Figure EMEA H1N1 Vaccines Sales Market Share in 2016
Table EMEA H1N1 Vaccines Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA H1N1 Vaccines Revenue Share by Region (2012-2017)
Figure Revenue Market Share of H1N1 Vaccines by Region (2012-2017)
Figure EMEA H1N1 Vaccines Revenue Market Share Regions in 2016
Table EMEA H1N1 Vaccines Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe H1N1 Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Europe H1N1 Vaccines Revenue and Growth Rate (2012-2017)
Table Europe H1N1 Vaccines Sales (K Units) by Type (2012-2017)
Table Europe H1N1 Vaccines Market Share by Type (2012-2017)
Figure Europe H1N1 Vaccines Market Share by Type in 2016
Table Europe H1N1 Vaccines Sales (K Units) by Application (2012-2017)
Table Europe H1N1 Vaccines Market Share by Application (2012-2017)
Figure Europe H1N1 Vaccines Market Share by Application in 2016
Table Europe H1N1 Vaccines Sales (K Units) by Countries (2012-2017)
Table Europe H1N1 Vaccines Sales Market Share by Countries (2012-2017)
Figure Europe H1N1 Vaccines Sales Market Share by Countries (2012-2017)
Figure Europe H1N1 Vaccines Sales Market Share by Countries in 2016
Table Europe H1N1 Vaccines Revenue (Million USD) by Countries (2012-2017)
Table Europe H1N1 Vaccines Revenue Market Share by Countries (2012-2017)
Figure Europe H1N1 Vaccines Revenue Market Share by Countries (2012-2017)
Figure Europe H1N1 Vaccines Revenue Market Share by Countries in 2016
Figure Germany H1N1 Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure France H1N1 Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure UK H1N1 Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Russia H1N1 Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Italy H1N1 Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux H1N1 Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East H1N1 Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East H1N1 Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East H1N1 Vaccines Sales (K Units) by Type (2012-2017)
Table Middle East H1N1 Vaccines Market Share by Type (2012-2017)
Figure Middle East H1N1 Vaccines Market Share by Type (2012-2017)
Table Middle East H1N1 Vaccines Sales (K Units) by Applications (2012-2017)
Table Middle East H1N1 Vaccines Market Share by Applications (2012-2017)
Figure Middle East H1N1 Vaccines Sales Market Share by Application in 2016
Table Middle East H1N1 Vaccines Sales Volume (K Units) by Countries (2012-2017)
Table Middle East H1N1 Vaccines Sales Volume Market Share by Countries (2012-2017)
Figure Middle East H1N1 Vaccines Sales Volume Market Share by Countries in 2016
Table Middle East H1N1 Vaccines Revenue (Million USD) by Countries (2012-2017)
Table Middle East H1N1 Vaccines Revenue Market Share by Countries (2012-2017)
Figure Middle East H1N1 Vaccines Revenue Market Share by Countries (2012-2017)
Figure Middle East H1N1 Vaccines Revenue Market Share by Countries in 2016
Figure Saudi Arabia H1N1 Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Israel H1N1 Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure UAE H1N1 Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Iran H1N1 Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Africa H1N1 Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Africa H1N1 Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa H1N1 Vaccines Sales (K Units) by Type (2012-2017)
Table Africa H1N1 Vaccines Sales Market Share by Type (2012-2017)
Figure Africa H1N1 Vaccines Sales Market Share by Type (2012-2017)
Figure Africa H1N1 Vaccines Sales Market Share by Type in 2016
Table Africa H1N1 Vaccines Sales (K Units) by Application (2012-2017)
Table Africa H1N1 Vaccines Sales Market Share by Application (2012-2017)
Figure Africa H1N1 Vaccines Sales Market Share by Application (2012-2017)
Table Africa H1N1 Vaccines Sales Volume (K Units) by Countries (2012-2017)
Table Africa H1N1 Vaccines Sales Market Share by Countries (2012-2017)
Figure Africa H1N1 Vaccines Sales Market Share by Countries (2012-2017)
Figure Africa H1N1 Vaccines Sales Market Share by Countries in 2016
Table Africa H1N1 Vaccines Revenue (Million USD) by Countries (2012-2017)
Table Africa H1N1 Vaccines Revenue Market Share by Countries (2012-2017)
Figure Africa H1N1 Vaccines Revenue Market Share by Countries (2012-2017)
Figure Africa H1N1 Vaccines Revenue Market Share by Countries in 2016
Figure South Africa H1N1 Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria H1N1 Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt H1N1 Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria H1N1 Vaccines Sales (K Units) and Growth Rate (2012-2017)
Table Medimmune H1N1 Vaccines Basic Information List
Table Medimmune H1N1 Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Medimmune H1N1 Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Medimmune H1N1 Vaccines Sales Market Share in EMEA (2012-2017)
Figure Medimmune H1N1 Vaccines Revenue Market Share in EMEA (2012-2017)
Table AstraZeneca H1N1 Vaccines Basic Information List
Table AstraZeneca H1N1 Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca H1N1 Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure AstraZeneca H1N1 Vaccines Sales Market Share in EMEA (2012-2017)
Figure AstraZeneca H1N1 Vaccines Revenue Market Share in EMEA (2012-2017)
Table Novartis H1N1 Vaccines Basic Information List
Table Novartis H1N1 Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis H1N1 Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Novartis H1N1 Vaccines Sales Market Share in EMEA (2012-2017)
Figure Novartis H1N1 Vaccines Revenue Market Share in EMEA (2012-2017)
Table GlaxoSmithKline H1N1 Vaccines Basic Information List
Table GlaxoSmithKline H1N1 Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline H1N1 Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure GlaxoSmithKline H1N1 Vaccines Sales Market Share in EMEA (2012-2017)
Figure GlaxoSmithKline H1N1 Vaccines Revenue Market Share in EMEA (2012-2017)
Table Serum Institute H1N1 Vaccines Basic Information List
Table Serum Institute H1N1 Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Serum Institute H1N1 Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Serum Institute H1N1 Vaccines Sales Market Share in EMEA (2012-2017)
Figure Serum Institute H1N1 Vaccines Revenue Market Share in EMEA (2012-2017)
Table Sinovac Biotech H1N1 Vaccines Basic Information List
Table Sinovac Biotech H1N1 Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sinovac Biotech H1N1 Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Sinovac Biotech H1N1 Vaccines Sales Market Share in EMEA (2012-2017)
Figure Sinovac Biotech H1N1 Vaccines Revenue Market Share in EMEA (2012-2017)
Table Zydus Cadila H1N1 Vaccines Basic Information List
Table Zydus Cadila H1N1 Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Zydus Cadila H1N1 Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Zydus Cadila H1N1 Vaccines Sales Market Share in EMEA (2012-2017)
Figure Zydus Cadila H1N1 Vaccines Revenue Market Share in EMEA (2012-2017)
Table BioCSL H1N1 Vaccines Basic Information List
Table BioCSL H1N1 Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure BioCSL H1N1 Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure BioCSL H1N1 Vaccines Sales Market Share in EMEA (2012-2017)
Figure BioCSL H1N1 Vaccines Revenue Market Share in EMEA (2012-2017)
Table Mitsubishi Tanabe Pharma H1N1 Vaccines Basic Information List
Table Mitsubishi Tanabe Pharma H1N1 Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Mitsubishi Tanabe Pharma H1N1 Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Mitsubishi Tanabe Pharma H1N1 Vaccines Sales Market Share in EMEA (2012-2017)
Figure Mitsubishi Tanabe Pharma H1N1 Vaccines Revenue Market Share in EMEA (2012-2017)
Table Protein Sciences Corporation H1N1 Vaccines Basic Information List
Table Protein Sciences Corporation H1N1 Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Protein Sciences Corporation H1N1 Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Protein Sciences Corporation H1N1 Vaccines Sales Market Share in EMEA (2012-2017)
Figure Protein Sciences Corporation H1N1 Vaccines Revenue Market Share in EMEA (2012-2017)
Table Baxter International H1N1 Vaccines Basic Information List
Table Sanofi Pastuer H1N1 Vaccines Basic Information List
Table Commonwealth Serum Laboratories (CSL) H1N1 Vaccines Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of H1N1 Vaccines
Figure Manufacturing Process Analysis of H1N1 Vaccines
Figure H1N1 Vaccines Industrial Chain Analysis
Table Raw Materials Sources of H1N1 Vaccines Major Manufacturers in 2016
Table Major Buyers of H1N1 Vaccines
Table Distributors/Traders List
Figure EMEA H1N1 Vaccines Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA H1N1 Vaccines Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA H1N1 Vaccines Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA H1N1 Vaccines Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA H1N1 Vaccines Sales Market Share Forecast by Region (2017-2022)
Table EMEA H1N1 Vaccines Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA H1N1 Vaccines Revenue Market Share Forecast by Region (2017-2022)
Table Europe H1N1 Vaccines Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe H1N1 Vaccines Sales Market Share Forecast by Countries (2017-2022)
Table Europe H1N1 Vaccines Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe H1N1 Vaccines Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East H1N1 Vaccines Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East H1N1 Vaccines Sales Market Share Forecast by Countries (2017-2022)
Table Middle East H1N1 Vaccines Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East H1N1 Vaccines Revenue Market Share Forecast by Countries (2017-2022)
Table Africa H1N1 Vaccines Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa H1N1 Vaccines Sales Market Share Forecast by Countries (2017-2022)
Table Africa H1N1 Vaccines Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa H1N1 Vaccines Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA H1N1 Vaccines Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA H1N1 Vaccines Sales Market Share Forecast by Type (2017-2022)
Table EMEA H1N1 Vaccines Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA H1N1 Vaccines Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources